申请人:Mitsubishi Tanabe Pharma Corporation
公开号:US20150065715A1
公开(公告)日:2015-03-05
The present invention relates to novel amidopyridine derivatives. More specifically, the present invention provides a medicinal agent which is useful as a prophylactic or therapeutic agent for diseases based on the production of cytokines from T cells, comprising as the active ingredient an amidopyridine derivative or a pharmacologically acceptable salt thereof. Provided are an amidopyridine derivative of the following general formula (I):
wherein each symbol has the same meaning as defined in the description, or a pharmacologically acceptable salt thereof.
本发明涉及新型的酰胺吡啶衍生物。更具体地说,本发明提供了一种药物剂,其作为预防或治疗基于T细胞产生细胞因子的疾病的药物剂,包括酰胺吡啶衍生物或其药理学上可接受的盐作为活性成分。提供了以下一般式(I)的酰胺吡啶衍生物,其中每个符号具有与描述中定义的相同含义,或其药理学上可接受的盐。